argenx to Present at Upcoming Investor Conferences

Rhea-AI Summary

On November 7, 2022, argenx (ARGX), a global immunology company, announced its participation in several investor conferences throughout November. Key events include:

• Guggenheim Healthcare Talks: Fireside chat on November 14 at 11:20 a.m. ET, New York.
• Stifel 2022 Healthcare Conference: Fireside chat on November 15 at 4:45 p.m. ET, New York.
• Jefferies London Healthcare Conference: Investor meetings on November 16, London.
• Evercore ISI 5th Annual HealthCONx Conference: Virtual chat on November 29 at 10:55 a.m. ET.
• Piper Sandler 34th Annual Healthcare Conference: Fireside chat on November 30 at 1:00 p.m. ET, New York.

Details on these events can be found on the argenx investor website.

November 7, 2022

Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that members of management will participate in several upcoming investor conferences in November:

• Guggenheim Healthcare Talks 4^th Annual Immunology and Neurology Day. Fireside chat on Monday, November 14, 2022 at 11:20 a.m. ET in New York, NY.
  
  
• Stifel 2022 Healthcare Conference. Fireside chat on Tuesday, November 15, 2022 at 4:45 p.m. ET in New York, NY.
  
  
• Jefferies London Healthcare Conference. Management will participate in investor meetings on Wednesday, November 16, 2022 in London, UK.
  
  
• Evercore ISI 5^th Annual HealthCONx Conference. Virtual fireside chat on Tuesday, November 29, 2022 at 10:55 a.m. ET.
  
  
• Piper Sandler 34^th Annual Healthcare Conference. Fireside chat on Wednesday, November 30, 2022 at 1:00 p.m. ET in New York, NY.
  
  

Additional information regarding these events will be available on the Investors section of the argenx website at argenx.com/investors.

About argenx

argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first-and-only approved neonatal Fc receptor (FcRn) blocker in the U.S., Japan and the EU. The Company is evaluating efgartigimod in multiple serious autoimmune diseases and advancing several earlier stage experimental medicines within its therapeutic franchises. For more information, visit www.argenx.com and follow us on LinkedIn, Twitter, and Instagram.

For further information, please contact:

Media:

Kelsey Kirk
kkirk@argenx.com

Investors:

Beth DelGiacco
bdelgiacco@argenx.com

FAQ

What investor conferences is argenx participating in November 2022?

argenx will participate in several conferences including Guggenheim Healthcare Talks on November 14, Stifel 2022 Healthcare Conference on November 15, and more.

When is the fireside chat at the Guggenheim Healthcare Talks?

The fireside chat at the Guggenheim Healthcare Talks is scheduled for November 14, 2022, at 11:20 a.m. ET.

Where will the Stifel 2022 Healthcare Conference take place?

The Stifel 2022 Healthcare Conference will take place in New York City on November 15, 2022.

What are the dates for the Jefferies London Healthcare Conference?

The Jefferies London Healthcare Conference will be held on November 16, 2022.

What time is the Evercore ISI HealthCONx Conference fireside chat?

The Evercore ISI 5th Annual HealthCONx Conference virtual fireside chat is on November 29, 2022, at 10:55 a.m. ET.

When will argenx present at the Piper Sandler Healthcare Conference?

The Piper Sandler 34th Annual Healthcare Conference fireside chat is on November 30, 2022, at 1:00 p.m. ET.